Terra Bioworks

Terra Bioforge is a private, pre-revenue biotechnology company founded in 2020 and based in San Francisco. It has built an integrated synthetic biology platform combining biosynthetic gene cluster cloning, organism engineering, and data sciences to engineer microbes for efficient natural product manufacturing. The company is targeting multiple markets with its platform technology, positioning itself as a potential partner for pharmaceutical and agri-science companies seeking novel compounds or improved production processes. Leadership includes experienced founders and advisors with backgrounds in synthetic biology, microbiology, and business development.

Integrated synthetic biology platform combining biosynthetic gene cluster (BGC) cloning, refactoring, and expression; custom genetic engineering of bacterial and fungal strains (including MycoDrive™); and data science (genomics, metabolomics) for accelerated discovery and scalable production of microbial natural products.

Terra Bioforge competes with other synthetic biology platform companies like Ginkgo Bioworks, Zymergen (now part of Ginkgo), and Synlogic, as well as agri-biotech firms engineering microbes. Its differentiation lies in its specific focus on and integrated tools for microbial natural products, particularly fungi (MycoDrive™), and its application-agnostic approach across health and agriculture sectors.